Although MOG antibodies are rarely found in MS, MOG-seropositive patients show neuropathological features that are similar to MS pattern II pathology with demyelinated lesions, preserved axons and complement-mediated pathology [17–20]. Here, MOG is linked to myeloid sarcoma.